All live data sources are unavailable in historical mode. I'll rely on the frozen FinMultiTime evidence block provided, which contains verified data from JPM's Q1 2024 10-Q filing (filed 2024-05-01). Let me compile a comprehensive report based on the available evidence.

---

# JPMorgan Chase & Co. (JPM) — Fundamental Analysis Report

**Analysis Date:** 2024-06-07 (Historical Run)
**Ticker:** JPM
**Data Source:** Frozen FinMultiTime Evidence (Q1 2024 10-Q, filed 2024-05-01)

---

## Executive Summary

This report analyzes JPMorgan Chase & Co. (JPM) using the available frozen fundamental evidence from its Q1 2024 (FY2024 Q1) condensed consolidated financial statements, filed with the SEC on May 1, 2024. **Important caveat:** All live fundamental data tools (get_fundamentals, get_balance_sheet, get_cashflow, get_income_statement) were **unavailable in historical mode** because they rely on yfinance, a LIVE_ONLY source. Therefore, this report is constructed exclusively from the frozen FinMultiTime evidence block, which provides verified point-in-time and quarterly figures from the 10-Q filing.

---

## 1. Balance Sheet Data (Point-in-Time, as of 2024-03-31)

From the condensed consolidated balance sheet (10-Q, FY2024 Q1):

| Metric | Value (USD) | Notes |
|--------|-------------|-------|
| **Total Assets** | $4,090,727,000,000 (~$4.09 trillion) | Point-in-time as of 2024-03-31 |
| **Total Liabilities** | $3,754,090,000,000 (~$3.75 trillion) | Point-in-time as of 2024-03-31 |
| **Stockholders' Equity** | $336,637,000,000 (~$336.6 billion) | Point-in-time as of 2024-03-31 |

**Key Balance Sheet Insights:**
- JPMorgan is the largest U.S. bank by assets, with total assets exceeding **$4.09 trillion**.
- The balance sheet is heavily leveraged, as is typical for a global systemically important bank (G-SIB). The **liability-to-asset ratio** is approximately **91.8%** ($3.754T / $4.091T).
- **Stockholders' equity** of ~$336.6 billion represents the bank's book value. This implies a **book value per share** that traders can use as a floor for valuation.
- The **equity-to-asset ratio** is approximately **8.2%**, reflecting the bank's capital position relative to its balance sheet size.

---

## 2. Cash Flow Statement Data (Quarterly, 2024-01-01 to 2024-03-31)

From the condensed consolidated statement of cash flows (10-Q, FY2024 Q1, 91-day period):

| Metric | Value (USD) | Notes |
|--------|-------------|-------|
| **Net Cash Provided by Operating Activities** | **-$154,158,000,000** (~-$154.2 billion) | Negative operating cash flow |
| **Net Cash Used in Investing Activities** | **-$43,379,000,000** (~-$43.4 billion) | Cash outflow from investing |
| **Net Cash Provided by Financing Activities** | **+$141,168,000,000** (~+$141.2 billion) | Cash inflow from financing |

**Key Cash Flow Insights:**
- **Operating cash flow was strongly negative** at -$154.2 billion for Q1 2024. This is a notable figure. For a large bank, operating cash flow can be volatile quarter-to-quarter due to changes in trading assets, loans, deposits, and other balance sheet items that flow through operating activities. A large negative operating cash flow in a single quarter is often driven by balance sheet growth (e.g., loan growth, securities purchases) rather than a deterioration in core profitability.
- **Investing activities** consumed -$43.4 billion, consistent with continued investment in securities and other long-term assets.
- **Financing activities** provided +$141.2 billion, indicating the bank raised funds (e.g., via deposits, long-term debt issuance, or other funding sources) to support the balance sheet expansion.
- The combination of negative operating cash flow (-$154.2B) offset by positive financing (+$141.2B) and negative investing (-$43.4B) reflects a quarter of significant balance sheet activity. The net change in cash would be approximately -$56.4 billion (-154.2 - 43.4 + 141.2 = -56.4B), though the exact net cash position is not provided in the frozen evidence.

---

## 3. Income Statement Data

**UNAVAILABLE:** No income statement data was provided in the frozen FinMultiTime evidence block. Revenue, net income, EPS, and profitability metrics for Q1 2024 are not available in the supplied evidence. Traders should note this gap.

---

## 4. Company Profile & Fundamentals

**UNAVAILABLE:** The get_fundamentals tool (which would provide company profile, valuation metrics, ratios, and comprehensive analysis) was unavailable in historical mode. No P/E ratio, market cap, dividend yield, or other standard fundamental metrics are available from the supplied evidence.

---

## 5. Financial History

**UNAVAILABLE:** Only Q1 2024 (FY2024 Q1) data is provided in the frozen evidence. No prior-period comparative data (e.g., Q1 2023, FY2023) is available to establish trends or year-over-year comparisons.

---

## 6. Analysis & Actionable Insights

### Strengths / Positive Signals
1. **Massive scale and balance sheet strength:** With $4.09 trillion in assets and $336.6 billion in equity, JPM remains the dominant U.S. banking franchise. The equity base provides substantial loss-absorption capacity.
2. **Capital adequacy:** The ~8.2% equity-to-asset ratio, while typical for a bank, reflects a solid capital position for a G-SIB. JPM is widely regarded as one of the best-capitalized large banks.
3. **Financing flexibility:** The bank raised $141.2 billion in financing during Q1, demonstrating strong access to funding markets.

### Concerns / Risk Signals
1. **Negative operating cash flow (-$154.2B):** This is a significant outflow that traders should monitor. While common for banks during balance-sheet expansion quarters, sustained negative operating cash flow could signal liquidity pressure. However, given JPM's scale and financing inflows, this appears manageable.
2. **High leverage (91.8% liabilities-to-assets):** As a G-SIB, JPM operates with high leverage by design. This amplifies both returns and risks, particularly in a rising-rate or credit-stress environment.
3. **Data limitations:** The absence of income statement data means profitability, revenue trends, and earnings quality cannot be assessed from this evidence. Traders should seek additional sources for net income and EPS figures.

### Trader Considerations
- The balance sheet and cash flow data suggest a bank actively deploying capital and growing its balance sheet in Q1 2024.
- The negative operating cash flow warrants monitoring but is not necessarily alarming for a bank of this size in a single quarter.
- Without income statement data, a full fundamental valuation (P/E, earnings growth) cannot be completed from this evidence alone.

---

## 7. Summary Table of Key Points

| Category | Metric | Value | Assessment |
|----------|--------|-------|------------|
| **Balance Sheet** | Total Assets | $4,090,727,000,000 | Largest U.S. bank; massive scale |
| **Balance Sheet** | Total Liabilities | $3,754,090,000,000 | High leverage (91.8% of assets) |
| **Balance Sheet** | Stockholders' Equity | $336,637,000,000 | Strong capital base (~8.2% of assets) |
| **Cash Flow** | Operating Cash Flow (Q1'24) | -$154,158,000,000 | Negative; monitor for liquidity |
| **Cash Flow** | Investing Cash Flow (Q1'24) | -$43,379,000,000 | Continued investment activity |
| **Cash Flow** | Financing Cash Flow (Q1'24) | +$141,168,000,000 | Strong funding access |
| **Income Statement** | Revenue / Net Income / EPS | **UNAVAILABLE** | Data gap in supplied evidence |
| **Company Profile** | Valuation / Ratios / Profile | **UNAVAILABLE** | Data gap in supplied evidence |
| **Financial History** | Prior-period comparatives | **UNAVAILABLE** | Only Q1'24 data provided |

---

## 8. Conclusion

Based on the available frozen evidence, JPMorgan Chase demonstrates a **large, well-capitalized balance sheet** with strong funding access, but shows a **notable negative operating cash flow** in Q1 2024 that traders should monitor. The most significant limitation of this analysis is the **absence of income statement data**, which prevents a complete profitability and earnings assessment.

**Recommendation:** Given the incomplete data (no income statement, no valuation metrics, no historical comparatives), a definitive BUY/HOLD/SELL recommendation cannot be fully substantiated from the supplied evidence alone. The balance sheet strength and capital position are positive, but the negative operating cash flow and data gaps warrant caution. Traders should seek additional fundamental data (net income, EPS, revenue, P/E) before making a final decision.

---

*Note: All live data tools were unavailable in historical mode (yfinance is LIVE_ONLY). This report relies exclusively on the frozen FinMultiTime evidence block from JPM's Q1 2024 10-Q filing (filed 2024-05-01). No events or facts occurring after 2024-06-07 were used.*